The biology of the metabolic syndrome and aging

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 19, Issue 1, 2016, Pages 5-11

  Dominguez, Ligia J ^a   Barbagallo, Mario ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

aging; inflammation; insulin resistance; metabolic syndrome; obesity

Indexed keywords

INSULIN; MAGNESIUM; SATURATED FATTY ACID;

AGING; CIRCADIAN RHYTHM; EPIGENETICS; GROUPS BY AGE; HUMAN; HYPOTHALAMUS; INFLAMMATION; INSULIN RESISTANCE; LIPID STORAGE; LONGEVITY; MAGNESIUM METABOLISM; METABOLIC SYNDROME X; OBESITY; OVERNUTRITION; REVIEW; SARCOPENIA; SARCOPENIC OBESITY; SENESCENCE; SKELETAL MUSCLE; TELOMERE; TELOMERE SHORTENING; ADIPOSE TISSUE; COMPLICATION; MUSCLE; PHYSIOLOGY;

ADIPOSE TISSUE; AGING; HUMANS; METABOLIC SYNDROME X; MUSCLES; OBESITY; SARCOPENIA;

EID: 84951905164     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000243     Document Type: Review

References (47)

1. Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States, 2003-2012. Jama 2015; 313:1973-1974.
2. Sepulveda J, Murray C. The state of global health in 2014. Science 2014; 345:1275-1278.
3. Morley JE. The metabolic syndrome and aging. J Gerontol A Biol Sci Med Sci 2004; 59:139-142.
4. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:766-781.
5. Yang Z, Zhang N. The burden of overweight and obesity on long-term care and Medicaid financing. Med Care 2014; 52:658-663.
6. Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2014; 2:819-829.
7. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014; 371:2237-2238.
8. Moore AZ, Caturegli G, Metter EJ, et al. Difference in muscle quality over the adult life span and biological correlates in the Baltimore Longitudinal Study of Aging. J Am Geriatr Soc 2014; 62:230-236.
9. Wannamethee SG, Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proc Nutr Soc 2015. [Epub ahead of print]
10. Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc 2014; 62:253-260.
11. Batsis JA, Barre LK, Mackenzie TA, et al. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc 2013; 61:974-980.
12. Johnson RJ, Stenvinkel P, Martin SL, et al. Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology. Obesity 2013; 21:659-664.
13. Jia G, Aroor AR, Whaley-Connell AT, Sowers JR. Fructose and uric acid: is there a role in endothelial function? Curr Hypertens Rep 2014; 16:434-445.
14. Hinnouho GM, Czernichow S, Dugravot A, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J 2015; 36:551-559.
15. Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. JAMA Intern Med 2014; 174:15-22.
16. Szendroedi J, Yoshimura T, Phielix E, et al. Role of diacylglycerol activation of PKCu in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci USA 2014; 111:9597-9602.
17. Magkos F, Su X, Bradley D, et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology 2012; 142:1444-1446; e1442.
18. Perry RJ, Zhang XM, Zhang D, et al. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Med 2014; 20:759-763.
19. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003; 300:1140-1142.
20. Riera CE, Dillin A. Tipping the metabolic scales towards increased longevity in mammals. Nat Cell Biol 2015; 17:196-203.
21. Martinez de Morentin PB, Martinez-Sanchez N, Roa J, et al. Hypothalamic mTOR: the rookie energy sensor. Curr Mol Med 2014; 14:3-21.
22. Liu M, Liu F. Regulation of adiponectin multimerization, signaling and function. Best Pract Res Clin Endocrinol Metab 2014; 28:25-31.
23. Dibaba DT, Xun P, Fly AD, et al. Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis. Diabet Med 2014; 31:1301-1309.
24. La SA, Lee JY, Kim DH, et al. Low magnesium levels in adults with metabolic syndrome: a meta-analysis. Biol Trace Elem Res 2015. [Epub ahead of print]
25. Barbagallo M, Di Bella G, Brucato V, et al. Serum ionized magnesium in diabetic older persons. Metabolism 2014; 63:502-509.
26. Dominguez LJ, Barbagallo M, Lauretani F, et al. Magnesium and muscle performance in older persons: the InCHIANTI study. Am J Clin Nutr 2006; 84:419-426.
27. Cederholm T, Morley JE. Sarcopenia, the new definitions. Curr Opin Clin Nutr Metab Care 2015; 18:1-4.
28. Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity 2015; 23:512-518.
29. Daniele G, Guardado-Mendoza R, Winnier D, et al. The inflammatory status score including IL-6, TNF-alpha, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 2014; 51:123-131.
30. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259:87-91.
31. Velloso LA, Folli F, Saad MJ. TLR4 at the crossroads of nutrients, gut microbiota, and metabolic inflammation. Endocr Rev 2015; 36:245-271.
32. DeWeerdt S. Microbiome: a complicated relationship status. Nature 2014; 508:S61-63.
33. Mukhopadhyay S, Mondal SA, Kumar M, Dutta D. Proinflammatory and antiinflammatory attributes of fetuin-A: a novel hepatokine modulating cardiovascular and glycemic outcomes in metabolic syndrome. Endocr Pract 2014; 20:1345-1351.
34. Samocha-Bonet D, Tam CS, Campbell LV, Heilbronn LK. Raised circulating fetuin-a after 28-day overfeeding in healthy humans. Diabetes Care 2014; 37:e15-16.
35. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014; 510:92-101.
36. Tang Y, Purkayastha S, Cai D. Hypothalamic microinflammation: a common basis of metabolic syndrome and aging. Trends Neurosci 2015; 38:36-44.
37. Yan J, Zhang H, Yin Y, et al. Obesity-and aging-induced excess of central transforming growth factor-beta potentiates diabetic development via an RNA stress response. Nat Med 2014; 20:1001-1008.
38. Li J, Tang Y, Purkayastha S, et al. Control of obesity and glucose intolerance via building neural stem cells in the hypothalamus. Mol Metab 2014; 3:313-324.
39. Revesz D, Milaneschi Y, Verhoeven JE, Penninx BW. Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome. J Clin Endocrinol Metab 2014; 99:4607-4615.
40. Haycock PC, Heydon EE, Kaptoge S, et al. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 2014; 349:g4227.
41. Garcia-Calzon S, Gea A, Razquin C, et al. Longitudinal association of telomere length and obesity indices in an intervention study with a Mediterranean diet: the PREDIMED-NAVARRA trial. Int J Obes 2014; 38:177-182.
42. Crous-Bou M, Fung TT, Prescott J, et al. Mediterranean diet and telomere length in Nurses' Health Study: population based cohort study. BMJ 2014; 349:g6674.
43. Szarc vel Szic K, Declerck K, Vidakovic M, Vanden Berghe W. From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition? Clin Epigenet 2015; 7:33.
44. Belancio VP, Blask DE, Deininger P, et al. The aging clock and circadian control of metabolism and genome stability. Front Genet 2014; 5:455.
45. Arellanes-Licea E, Caldelas I, De Ita-Perez D, Diaz-Munoz M. The circadian timing system: a recent addition in the physiological mechanisms underlying pathological and aging processes. Aging Dis 2014; 5:406-418.
46. Lopez-Garcia E, Rodriguez-Artalejo F, Li TY, et al. The Mediterranean-style dietary pattern and mortality among men and women with cardiovascular disease. Am J Clin Nutr 2014; 99:172-180.
47. Pahor M, Guralnik JM, Ambrosius WT, et al. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA 2014; 311:2387-2396.